A Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension
Trial ID or NCT#
This study will evaluate the 24-hour intraocular pressure lowering effect and safety after a single administration of Bimatoprost SR in patients with Open-Angle Glaucoma or Ocular Hypertension
An Evaluation of the 24-Hour Intraocular Pressure(IOP)-Lowering Effect of Bimatoprost Sustained-Release(SR) in Participants With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)
- - Diagnosis of either OAG or OHT study eye, requiring IOP-lowering treatment - Participant is currently a nonsmoker and has not smoked any nicotine-containing products within the previous 6 months
- - Current or anticipated enrollment in another investigational drug or device study - Females who are pregnant, nursing, or planning a pregnancy during the study
Contact us to find out if this trial is right for you.